01801.HK
Innovent Biologics, Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 81.60
+0.43%Leverage
- Debt / equity
- 0.11x
- Net debt / equity
- -0.73x
- Debt / assets
- 0.06x
- Debt / EBITDA
- 0.91x
- Net debt / EBITDA
- -5.92x
Liquidity & coverage
- Current ratio
- 2.68x
- Quick ratio
- 2.48x
- Cash ratio
- 2.15x
- Interest coverage
- 32.09x
- EBITDA / interest
- 43.52x
- Working capital
- HKD 18.4B
Cash & dividend
- FCF / debt
- 5.60x
- Cash flow / debt
- 5.77x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026